This Study Tests How Healthy Men Tolerate Different Doses of BI1015550. The Study Also Tests How BI 1015550 is Taken up by the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

August 10, 2017

Primary Completion Date

January 16, 2018

Study Completion Date

January 16, 2018

Conditions
Healthy
Interventions
DRUG

BI 1015550

Part 1 - single rising dose. Part 2 multiple rising dose

DRUG

Placebo

Part 1 - single rising dose. Part 2 multiple rising dose

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY